INDEGENE LIMITED FILES DRHP WITH SEBI TO FLOAT IPO

MUMBAI, 16 DECEMBER, 2022 (TGN): Indegene Limited, a digital-first commercialization company focused exclusively on the global life sciences industry has filed its Draft Red Herring Prospectus (“DRHP”) with market regulator Securities and Exchange Board of India (“SEBI”). The Company’s initial public offering comprises a fresh issue of up to Rs. 9,500 million and an offer for sale of … Continue reading INDEGENE LIMITED FILES DRHP WITH SEBI TO FLOAT IPO